MoneyWorks4Me

Colinz Laboratories - Quaterly Results

25 Jan 2026 Evaluate
The revenue slipped marginally during the December 2025 quarter. A decline of about Rs. 14.34 millions was observed as compared to Rs. 14.66 millions during the corresponding quarter last year.Handsome Net Profit growth of 55.56% reported above the corresponding previous quarter figure of Rs. 0.84 millions to Rs. 0.54 millions.Operating profit surged to 1.77 millions from the corresponding previous quarter of 1.41 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 14.34 14.66 -2.18 43.88 50.76 -13.55 65.28 70.30 -7.14
Other Income 0.75 0.77 -2.60 3.09 2.22 39.19 2.98 2.75 8.36
PBIDT 1.77 1.41 25.53 6.26 6.19 1.13 7.94 8.17 -2.82
Interest 0.11 0.05 120.00 0.36 0.26 38.46 0.42 0.37 13.51
PBDT 1.66 1.36 22.06 5.90 5.93 -0.51 7.52 7.80 -3.59
Depreciation 0.39 0.32 21.88 1.17 0.96 21.88 1.31 1.30 0.77
PBT 1.27 1.04 22.12 4.73 4.97 -4.83 6.21 6.50 -4.46
TAX 0.43 0.50 -14.00 1.31 1.50 -12.67 1.23 1.64 -25.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.52 -0.02 2500.00
PAT 0.84 0.54 55.56 3.42 3.47 -1.44 4.98 4.86 2.47
Equity 25.19 25.19 0.00 25.19 25.19 0.00 25.19 25.19 0.00
PBIDTM(%) 12.34 9.62 28.33 14.27 12.19 16.99 12.16 11.62 4.66
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..